Add Row
Add Element
My Wellness Train Network
update
My Wellness Train™ Network
cropper
update
Add Element
  • Menu 1
  • Menu 2
  • Menu 3
  • Menu 4
  • Menu 5
  • Menu 6
Add Element
  • update
  • update
  • update
  • update
  • update
  • update
  • update
February 09.2025
2 Minutes Read

Unmasking the Alarming Truth: Heavy Cannabis Use Harms Health

Glass jar with cannabis buds on wooden surface, Cannabis Use Disorder context.

The Hidden Risks of Heavy Cannabis Use

As cannabis becomes increasingly normalized in society, a growing body of evidence warns that heavy use could pose significant health risks. Recent studies published in JAMA Network Open found alarming correlations between cannabis use disorder (CUD) and health issues, suggesting that individuals who regularly consume marijuana are at a heightened risk of death, particularly by suicide or due to other serious health conditions. The findings highlight a need for greater awareness and proactive measures for those impacted by cannabis use.

Understanding Cannabis Use Disorder and Its Implications

CUD isn't just a label; it represents a deeper public health concern. Research showed that about 3.5% of individuals treated for CUD died within five years compared to just 0.6% of those without the disorder. The higher death rate reflects a concerning reality that many don't consider when thinking about recreational cannabis use. Young adults, especially those between 25 and 44 years old, emerged as the most at-risk group. This demographic could benefit immensely from preventive interventions and psychological support.

The Rise of Psychosis: A Worrying Trend

The studies didn't stop at death rates; they also examined mental health implications. Since Canada legalized recreational marijuana in 2018, rates of psychosis linked to CUD have surged. Prior to legalization, psychotic cases attributed to cannabis accounted for only 3.7% of schizophrenia diagnoses; however, this figure skyrocketed to 10.3% after legalization. Young adults aged 19 to 24 are particularly vulnerable during this critical time of brain development.

Potency Matters: A Generational Shift in Cannabis

It is essential to consider that today's marijuana is significantly stronger than what past generations encountered. This increase in potency comes with heightened health risks that need addressing. Experts, particularly in psychological and medical fields, warn that just because cannabis is marketed as 'natural' doesn't mean it's harmless. Society must shift its perception of cannabis from a harmless substance to one that can carry serious health implications.

Encouraging Open Dialogues About Health Risks

This research presses for open conversations surrounding cannabis use, especially among younger generations. Awareness of these risks can lead to more informed decisions regarding recreational use. By understanding the realities of cannabis use disorder, individuals can take proactive steps in safeguarding their mental and physical health.

Healthy Aging and Longevity

16 Views

0 Comments

Write A Comment

*
*
Related Posts All Posts
09.20.2025

FDA Cracks Down on Telehealth Drug Advertising: What You Should Know

Update FDA Takes Action Against Telehealth Companies for Misleading AdsOn September 17, 2025, the FDA made a significant move to protect consumer health by issuing over 100 warning letters to telehealth companies and drug manufacturers. The focus of the crackdown primarily lies on misrepresentations regarding popular prescription drugs, particularly weight loss medications. Among the companies targeted is Hims & Hers, known for promoting affordable alternatives to widely used medications like Ozempic and Wegovy.Hims has faced criticism for claiming its compounded products contain "the same active ingredient" as FDA-approved versions, a statement the FDA argues is misleading. These compounded medications come from pharmacies mixing ingredients, and they have not undergone FDA review, which raises concerns about their safety and efficacy.The Implications of FDA Listings on Telehealth MarketingThis regulatory action marks the FDA's first direct engagement with online health platforms like Hims, which have traditionally claimed that established drug advertising regulations do not apply to them. By demanding compliance, the FDA is emphasizing the importance of clear and truthful messaging in the pharmaceutical advertising landscape.Potential Patient Risks and What They Need to KnowPatients relying on custom compounded medications should be particularly vigilant. Compounding can sometimes be beneficial, particularly when an FDA-approved drug isn’t available. However, as federal regulators assert that significant shortages of certain medications no longer exist, the necessity for compounded alternatives diminishes. Patients must consider the risks associated with using compounded drugs, which may not provide the same therapeutic effects as standardized medications.Consumer Awareness: How to Navigate Medication ChoicesFor consumers aiming to understand complex prescription drug information, consulting healthcare professionals is crucial to navigate the nuances of medication options. Tools such as medication safety information guides and interaction checkers can help shed light on potential side effects, contraindications, and the appropriate use of medications, ensuring safer health choices. Additionally, staying informed about drug recalls and safety alerts protects individuals from potential harm.Conclusion: A Call for Vigilance in Telehealth PracticesThis FDA action highlights the essential vigilance required by consumers in the ever-evolving landscape of telehealth. Individuals should be proactive in understanding the medications they take and seek advice from healthcare professionals regarding any decisions. Contact us for more details on how to make informed health choices.

09.20.2025

Utilizing Hair Samples to Spot Mental Health Risks in Sick Kids

Update Understanding the Hidden Struggles of Chronically Ill Children Children facing chronic illnesses such as diabetes, arthritis, or cystic fibrosis endure not just physical challenges, but emotional ones as well. Research from the University of Waterloo highlights the intricate link between chronic health conditions and mental health risks, demonstrating how the complexities of living with a chronic condition can lead to severe psychological stress. The Role of Hair Samples in Monitoring Stress Recent studies have opened a new avenue in mental health research by utilizing hair samples to track cortisol levels, the body's primary stress hormone. By analyzing cortisol concentrations over time, healthcare providers can gain a clearer picture of a child's stress levels. This method is not only non-invasive but also allows for a longitudinal assessment of a child's emotional well-being, with higher levels of cortisol warning of potential anxiety and depression concerns. The Importance of Early Intervention Identifying children with consistently high cortisol levels is crucial. Emma Littler, the study's lead author, emphasizes that early detection can lead to timely interventions before emotional or behavioral issues escalate. The linkage between chronic illness and mental health underscores the necessity for comprehensive care that addresses both physical and psychological needs. Health Implications for Families and Health Care Providers Nearly 40% of Canadian children live with a chronic condition, significantly increasing their risk for emotional difficulties and requiring greater reliance on healthcare resources. Recognizing the psychological impact of their physical health conditions is essential for families and providers alike. Understanding this dual burden can equip caregivers with the tools to support their children's mental health effectively. Conclusion: What Can You Do? The implications of these findings are significant; families and healthcare professionals must be proactive in monitoring mental health alongside physical health in children with chronic illnesses. Knowing how to assess stress levels through cortisol testing can empower you to seek appropriate interventions. For more details on how to advocate for your child's mental well-being, contact us for more details.

09.19.2025

U.S. Officials Review COVID Vaccine Safety for Pregnant Women and Kids

Update Understanding Vaccine Safety for Pregnant Women and ChildrenIn a crucial development for public health, U.S. officials are conducting a review of COVID vaccine safety specifically concerning pregnant women and children. This review, announced by the FDA, aims to address potential health concerns, especially after reports of adverse events have emerged amidst the vaccination rollout over the past few years. The upcoming meeting on September 18 and 19, hosted by the CDC's vaccine advisory group, reflects the ongoing commitment to thorough vaccine safety scrutiny.The Role of VAERS in Vaccine Safety MonitoringThe Vaccine Adverse Event Reporting System, or VAERS, is central to this review. Experts assert that VAERS is not designed to establish causality but rather to identify potential safety signals by gathering reports of adverse events. Dr. Demetre Daskalakis, former director of the CDC's National Center for Immunization and Respiratory Diseases, emphasizes that while VAERS allows for the generation of hypotheses regarding vaccine safety, it does not provide definitive evidence that vaccines are responsible for health issues.Current Findings on Vaccine Safety in PregnancyCurrent data offers some reassurance to expectant mothers. Comprehensive studies monitoring over 68,000 pregnant women show no heightened risk of major birth defects, miscarriage, or other serious complications associated with COVID vaccines. For example, Pfizer's clinical trial reported rates of birth defects among vaccinated participants that mirrored those in the general population, suggesting that when vaccinated, pregnant women do not face significant additional risks. This evidence highlights the continued commitment of health authorities to prioritize both maternal and fetal health.The Potential Shift in Vaccine RecommendationsIn addition to scrutinizing data related to vaccinated pregnant women and children, the CDC advisory group may also contemplate adjustments to existing vaccine guidelines for older adults, potentially shifting recommendations to focus on those aged 75 and older or younger adults with pre-existing health conditions. Currently, vaccinations remain available for adults aged 65 and older and those at high risk for severe illness.Looking Ahead: Improving Public Confidence in VaccinationAs federal health officials work to clarify these important safety evaluations, it is imperative for the medical community and the public to remain informed. The plans to share safety data transparently will be crucial in bolstering confidence among populations that may have concerns about vaccinations. Engaging in discussions about potential risks, and evolving recommendations can foster a more informed public dialogue.In summary, understanding the evaluation of COVID vaccine safety during pregnancy and in children provides essential context for ongoing public health measures. Continue to educate yourself and reach out for tailored medical advice regarding vaccinations.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*